WAKEFIELD, Mass., April 12, 2022 – PRESS RELEASE – Curaleaf Holdings Inc.,
a leading international provider of consumer CBD and hemp products, announced
that its Select CBD and Curaleaf Hemp products will become available for the
first time in the Caribbean market thanks to a new distribution agreement with
WB Canna Co. & Wellness. This agreement will bring Curaleaf's lineup of
products from its eponymous Hemp and Select CBD product lines to customers in,
and traveling throughout, the U.S. Virgin Islands, Puerto Rico, Aruba, Bermuda,
Barbados, Cayman, Costa Rica, Guatemala, Jamaica, and Saint Maarten, as well as
additional markets in Latin America, travel retail, and the cruise and
diplomatic channel.
WB
Canna Co. & Wellness is a wholly owned subsidiary of Miami-based WEBB
Banks, the leading premium wine and spirits distributor in the Caribbean
and one of the first companies in the region focused on distribution of
top-quality CBD and wellness products. The distribution relationship combines
Curaleaf's expertise in creating high-quality non-psychoactive hemp products
with WB Canna Co.'s ability to navigate the legal and compliance needs across
the fragmented geography of the Caribbean, bringing operating efficiencies that
will drive further accessibility to Curaleaf's family of CBD products.
Curaleaf
Hemp offers a broad range of CBD products with consumer-friendly formats and
price points to select retailers throughout the U.S. A collection of all-new
Select CBD products that feature minor cannabinoids like CBN and CBG, are
slated to debut in April. All Curaleaf and Select CBD products are subjected to
stringent industry testing practices.
"We
are committed to setting the highest possible standards for product quality and
accessibility at Curaleaf, and we are thrilled to expand the reach of our
award-winning CBD products to retail stores in the Caribbean through a
distribution partner like WB Canna Co. It continues to be of utmost importance
that we're able to provide consumers with reliable access to the products they know
and love," said Patrick Larkin, senior vice president of sales at
Curaleaf.
"We
believe that consumer demand for high-quality CBD products will continue to
grow year-over-year, and we remain laser-focused on building brand recognition
and brand loyalty," said Joseph Gennaro, VP of CBD, Health & Wellness
at Curaleaf. "Consequently, our agreement with WB Canna Co. marks a key
inflection point in the go-to-market strategy for our CBD business and shows
our commitment to achieving international growth."
"In
the short time since launching WB Canna Co. and Wellness early last year, we've
seen incredible interest and excitement for high-quality CBD and wellness
products throughout the Caribbean and Latin America," said Phillip
Jarrell, chief operating officer of WB Canna Co. & Wellness. "We're
very proud to add Curaleaf to our growing portfolio and introduce their popular
and innovative products to consumers across the region."
CBD
products that are derived from hemp contain less than 0.3% THC and have been
legal at the federal level since the passing of the Farm Bill in 2018. As a
precaution, we recommend researching the CBD laws and regulations of your
destination, as well as any countries or states you are traveling through en
route to your destination. You should also thoroughly understand the products
in your possession, and whether they contain any THC or are purely
CBD. TSA rules apply. The statements above have not been evaluated by the
U.S. Food and Drug Administration. These products are not intended to diagnose,
treat, cure or prevent any disease.
For
more information, please visit CuraleafHemp.com and SelectCBD.com.